TOFAZ-5 and TOFAZ XR 11 contain Tofacitinib, an FDA-approved JAK inhibitor that helps manage chronic autoimmune diseases by reducing inflammation and preventing joint and tissue damage. These medications provide targeted relief for patients with:
Rheumatoid Arthritis (RA) – Reduces joint pain, swelling, and stiffness.
Psoriatic Arthritis (PsA) – Controls inflammation and prevents joint damage.
Ulcerative Colitis (UC) – Alleviates symptoms like diarrhea, rectal bleeding, and abdominal pain.
Choose TOFAZ-5 & TOFAZ XR 11 for superior inflammation control and symptom relief!
Why Choose TOFAZ-5 & TOFAZ XR 11?
Targeted JAK Inhibitor Therapy – Blocks key inflammation pathways.
Rapid Symptom Relief – Improves mobility and reduces pain quickly.
Effective for Multiple Autoimmune Disorders – Treats RA, PsA, and UC.
Oral Tablet Convenience – No injections required.
Extended-Release (XR) Formulation Available – Ensures long-lasting relief with once-daily dosing.
Key Ingredient & Its Benefits
Tofacitinib (5 mg in TOFAZ-5 & 11 mg SR in TOFAZ XR 11)
- Inhibits Janus Kinase (JAK) pathways to regulate immune response.
- Reduces inflammation, pain, and swelling in arthritis patients.
- Prevents joint damage and maintains mobility.
- Controls symptoms of ulcerative colitis by reducing gut inflammation.
TOFAZ-5 & TOFAZ XR 11 provide targeted immune modulation for long-term disease management!
Indications
Rheumatoid Arthritis (RA) Patients – Controls inflammation and prevents joint destruction.
Psoriatic Arthritis (PsA) Patients – Reduces swelling and improves movement.
Ulcerative Colitis (UC) Patients – Treats flare-ups and maintains remission.
Patients Unresponsive to Conventional DMARDs – Suitable for those who do not respond to methotrexate or biologics.
TOFAZ-5 & TOFAZ XR 11 are essential for managing autoimmune disorders effectively!
Dosage & Administration
TOFAZ-5 (Tofacitinib 5 mg Tablets):
Rheumatoid Arthritis & Psoriatic Arthritis: 5 mg twice daily (morning & evening).
Ulcerative Colitis: Induction Dose: 10 mg twice daily for 8 weeks, followed by a maintenance dose of 5 mg twice daily.
TOFAZ XR 11 (Tofacitinib 11 mg SR Tablets):
Rheumatoid Arthritis & Psoriatic Arthritis: 11 mg once daily with or without food.
Ulcerative Colitis: 22 mg once daily for 8 weeks, then 11 mg once daily for maintenance.
Take as prescribed by your doctor for optimal results!
Precautions & Warnings
Avoid in Active Infections – Can increase infection risk.
Regular Blood Monitoring Required – To check white blood cell count and liver function.
Not for Pregnant or Breastfeeding Women – Consult your doctor before use.
Use with Caution in Liver & Kidney Disorders – Dosage adjustment may be needed.
May Increase Risk of Blood Clots – Inform your doctor if you have a history of clotting disorders.
Possible Side Effects:
Mild (Common): Headache, nausea, diarrhea, mild infections.
Serious (Rare): Severe infections, blood clots, liver dysfunction, or increased cholesterol levels.
Seek medical attention if you experience severe infections, chest pain, or difficulty breathing.
TOFAZ-5 (Tofacitinib 5 mg) & TOFAZ XR 11 (Tofacitinib 11 mg SR) are clinically approved, highly effective oral treatments for rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. With a targeted JAK inhibition mechanism, these medications reduce inflammation, pain, and joint damage, helping patients regain mobility and quality of life.
Clinically Approved | Safe & Effective | Doctor-Recommended
Choose TOFAZ-5 & TOFAZ XR 11 for long-term autoimmune disease relief today!
Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category Miscellaneous
You can also contact us www.allengeindia.com/contact-us
